R A Stephenson

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen
    R A Stephenson
    Department of Surgery, University of Utah School of Medicine, Salt Lake City 84132, USA
    World J Urol 15:331-5. 1997
  2. ncbi request reprint Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study
    Robert A Stephenson
    From the Division of Urology, University of Utah School of Medicine, Salt Lake City, Utah 8411132, USA
    J Urol 174:646-50; discussion 650. 2005
  3. ncbi request reprint Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database
    Robert A Stephenson
    Division of Urology, Department of Surgery, University of Utah School of Medicine, 50 North Medical Drive, Room 3B420, Salt Lake City, UT 84132, USA
    Urol Clin North Am 29:173-81. 2002
  4. ncbi request reprint Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status
    Timothy A Masterson
    Division of Urology, Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Urology 66:152-5. 2005
  5. ncbi request reprint 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study
    David F Penson
    Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA
    J Urol 173:1701-5. 2005
  6. ncbi request reprint Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study
    Arnold L Potosky
    Division of Cancer Control and Population Sciences, National Cancer Institute, EPN Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 96:1358-67. 2004
  7. ncbi request reprint Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location
    Joseph A Pettus
    Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA
    J Urol 172:129-32. 2004
  8. pmc Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study
    Richard M Hoffman
    Medicine Service, New Mexico VA Health Care System, Albuquerque, NM 87108, USA
    J Gen Intern Med 18:845-53. 2003
  9. doi request reprint Risk stratification for positive lymph nodes in prostate cancer
    Joseph A Pettus
    Department of Urology, University of Utah, Salt Lake City, Utah 84132, USA
    J Endourol 22:1021-5. 2008
  10. ncbi request reprint Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics
    Joseph A Pettus
    Department of Human Genetics, University of Utah School of Medicine, 1C210 SOM, 30 North 1900 East, Salt Lake City, UT 84132 2117, USA
    Cancer Genet Cytogenet 154:110-8. 2004

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen
    R A Stephenson
    Department of Surgery, University of Utah School of Medicine, Salt Lake City 84132, USA
    World J Urol 15:331-5. 1997
    ..Local treatment rates, particularly radical prostatectomy rates, have risen substantially. Mortality rates appear to have leveled or declined slightly since 1991 after years of steady rise...
  2. ncbi request reprint Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study
    Robert A Stephenson
    From the Division of Urology, University of Utah School of Medicine, Salt Lake City, Utah 8411132, USA
    J Urol 174:646-50; discussion 650. 2005
    ..We report use and treatment outcomes in a 5-year interval in a population based cohort from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study...
  3. ncbi request reprint Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database
    Robert A Stephenson
    Division of Urology, Department of Surgery, University of Utah School of Medicine, 50 North Medical Drive, Room 3B420, Salt Lake City, UT 84132, USA
    Urol Clin North Am 29:173-81. 2002
    ..Given the long delay between treatment and mortality that is inherent in prostate cancer (Fig. 14), the full effects of treatment on prostate cancer mortality are probably not yet seen in prostate cancer mortality data...
  4. ncbi request reprint Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status
    Timothy A Masterson
    Division of Urology, Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Urology 66:152-5. 2005
    ....
  5. ncbi request reprint 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study
    David F Penson
    Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA
    J Urol 173:1701-5. 2005
    ..In this study we assessed temporal changes in urinary and sexual function up to 5 years following radical prostatectomy in a population based cohort...
  6. ncbi request reprint Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study
    Arnold L Potosky
    Division of Cancer Control and Population Sciences, National Cancer Institute, EPN Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 96:1358-67. 2004
    ..We present treatment-specific quality-of-life outcomes for prostate cancer patients 5 years after initial diagnosis...
  7. ncbi request reprint Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location
    Joseph A Pettus
    Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA
    J Urol 172:129-32. 2004
    ..We examine the effects of margin status and location on biochemical recurrence rates in patients undergoing RRP...
  8. pmc Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study
    Richard M Hoffman
    Medicine Service, New Mexico VA Health Care System, Albuquerque, NM 87108, USA
    J Gen Intern Med 18:845-53. 2003
    ..We examined whether there were racial differences in initial treatment for clinically localized prostate cancer and investigated whether demographic, socioeconomic, clinical, or tumor characteristics could explain any racial differences...
  9. doi request reprint Risk stratification for positive lymph nodes in prostate cancer
    Joseph A Pettus
    Department of Urology, University of Utah, Salt Lake City, Utah 84132, USA
    J Endourol 22:1021-5. 2008
    ..To evaluate the risk of positive lymph nodes using preoperative clinical parameters...
  10. ncbi request reprint Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics
    Joseph A Pettus
    Department of Human Genetics, University of Utah School of Medicine, 1C210 SOM, 30 North 1900 East, Salt Lake City, UT 84132 2117, USA
    Cancer Genet Cytogenet 154:110-8. 2004
    ..We propose this technology for the evaluation of prostate and other heterogeneous cancers as a rapid and efficient way to detect genetic copy number changes...
  11. ncbi request reprint Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study
    Richard M Hoffman
    Medicine Service, New Mexico VA Health Care System, Albuquerque, New Mexico 87108, USA
    Cancer 97:1653-62. 2003
    ....
  12. ncbi request reprint General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study
    David F Penson
    Section of Urology, VA Puget Sound Health Care System and the Department of Urology, University of Washington, Seattle, WA 98108, USA
    J Clin Oncol 21:1147-54. 2003
    ..The goal of this study was to determine the relationship between primary treatment, urinary dysfunction, sexual dysfunction, and general health-related quality of life (HRQOL) in prostate cancer...
  13. ncbi request reprint Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy
    Arnold L Potosky
    Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD
    J Natl Cancer Inst 94:430-7. 2002
    ..Treatment patterns and quality-of-life outcomes have not been previously reported for a population-based sample of such men...